24G-70676-61222
3 vaccinations
2 coded responses
34 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 402 / KY
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-23
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
- 2021-01-11
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-03
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-14
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-16
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-10
-
2021-12-29
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: Diagnosed with Covid-19MedDRA releases: 2024-11 · check-in free text available
- 2022-03-30
-
2022-09-29
Survey response — 12 months, dose 3MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Gestational diabetesMedDRA releases: 2024-11 · check-in free text available
-
2022-09-29
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-29 | Unsuccessful |
Free text
Release 10 — 3 months, dose 3
Symptoms: Diagnosed with Covid-19
Release 12 — 12 months, dose 3
Symptoms: Gestational diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Gestational diabetes | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release